LeMaitre Vascular, Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: +13.3%
EBITDA: +34.3%
EBIT: +37.8%
EPS: +36.6%
Free cash flow: +92.4%
Operating cash flow: +81.5%

Forward estimates

Revenue: +14.2%
EBITDA: -17.6%
EPS: +10.3%

Three-year CAGR

Revenue: +15.6%
EBITDA: +35.0%
EBIT: +36.3%
Net income: +40.9%
EPS: +39.5%
Free cash flow: +49.8%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.